Anxiety crisis (panic attack) secondary to the administration of theophylline in an oral sustained-release preparation
Gea, J.; de Pablo, J.; Martí, J.; Picado, C.; Pujol, A.; Agustí-Vidal, A.
Revista Clinica Espanola 183(5): 280
1988
ISSN/ISBN: 0014-2565 PMID: 3212257 Document Number: 310055
Document emailed within 1 workday
Related Documents
Weiss, G.; Klemm, F.H.; Fuchs, W.S.; Stanislaus, F.; Zema, M.; Calanchi, M. 1998: Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension Arzneimittel-Forschung 48(5a): 604-612Rachelefsky, G.S.; Katz, R.M.; Siegel, S.C. 1978: A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels Annals of Allergy 40(4): 252-257
Bourgeois, M. 1993: Stress, anxiety, panic. Panic attack and panic disorder. a new psychiatric concept L'Encephale 19(Special Issue 1): 187-191
McKenzie, S.; Baillie, E. 1979: Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets) Journal of International Medical Research 7(Suppl 1): 22-27
Steinijans, V.W.; Trautmann, H.; Sauter, R.; Staudinger, H. 1988: Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration Arzneimittel-Forschung 38(8a): 1251-1253
Jones, D.T.; Sears, M.R. 1980: Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations New Zealand Medical Journal 92(667): 196-198
Fairhurst, E.; Dale, T.L.; Ridge, B.D. 1978: Biochemical responses of women with low storage iron to a sustained release preparation of oral Fe Proceedings of the Nutrition Society 37(2): 41A
Baronti, A.; Verdiani, P.; Di Carlo, S. 1987: Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily La Clinica Terapeutica 122(6): 437-440
Tröger, U.; Martens, J.; Meyer, F.P.; Hoffmann, A.; Terhaag, B. 1995: Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses Arzneimittel-Forschung 45(12): 1266-1270
Assinder, D.F.; Chasseaud, L.F.; Hunter, J.O.; Jung, R.J.; Taylor, T. 1977: Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects Arzneimittel-Forschung 27(1): 156-158
Lagas, M.; Jonkman, J.H. 1985: Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet International Journal of Clinical Pharmacology Therapy and Toxicology 23(8): 424-426
Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. 1980: Absorption of theophylline from conventional and sustained-release tablets European Journal of Respiratory Diseases. Supplement 109: 54-60
Zhang, Y.; Huang, G.; Yu, Y.; Han, J.; Yu, P. 2006: Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 23(3): 597-600; 614
Rey, H.; Wagner, K.G.; Wehrlé, P.; Schmidt, P.C. 2000: Development of matrix-based theophylline sustained-release microtablets Drug Development and Industrial Pharmacy 26(1): 21-26
Newth, C.J.; Isles, A.F. 1984: Assessment of a sustained release capsule and a tablet formulation of theophylline British Journal of Clinical Practice. Suppl 35: 53-54
Ritschel, W.A.; Koch, H.P.; Alcorn, G.J. 1984: In vivo-in vitro correlations with sustained-release theophylline preparations Methods and Findings in Experimental and Clinical Pharmacology 6(10): 609-618
Ferrari, M.; Olivieri, M.; Romito, D.; Biasin, C.; Barozzi, E.; Bassetti, S. 1991: Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline Rivista Europea Per le Scienze Mediche e Farmacologiche 13(5-6): 269-274
Lin, S.Y.; Yang, J.C. 1989: In-vitro dissolution behavior of some sustained-release theophylline dosage forms Pharmaceutica Acta Helvetiae 64(8): 236-240
Battistini, A.; Grzincich, G.L.; Ferrara, D. 1986: Criteria for discontinuation of sustained-release theophylline in children with chronic asthma La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 8(5): 665-669
Jonkman, J.H.; van der Boon, W.J.; Schoenmaker, R.; Holtkamp, A.; Thürkow-Luikens, A.J. 1984: The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 506-510